| 1 |
35070302 | Therapeutic efficacy of lenvatinib for hepatocellular carcinoma with iso-high intensity in the hepatobiliary phase of Gd-EOB-DTPA-MRI. | 2022 Feb |
1 |
| 2 |
35159095 | Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma. | 2022 Feb 6 |
1 |
| 3 |
34298844 | Characteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRI. | 2021 Jul 20 |
1 |
| 4 |
34950184 | Higher Enhancement Intrahepatic Nodules on the Hepatobiliary Phase of Gd-EOB-DTPA-Enhanced MRI as a Poor Responsive Marker of Anti-PD-1/PD-L1 Monotherapy for Unresectable Hepatocellular Carcinoma. | 2021 Nov |
1 |
| 5 |
31834849 | Hyperintense Liver Masses at Hepatobiliary Phase Gadoxetic Acid-enhanced MRI: Imaging Appearances and Clinical Importance. | 2020 Jan-Feb |
1 |
| 6 |
33083276 | Gd-EOB-DTPA-MRI Could Predict WNT/β-Catenin Mutation and Resistance to Immune Checkpoint Inhibitor Therapy in Hepatocellular Carcinoma. | 2020 Sep |
1 |
| 7 |
28488786 | Gadoxetic acid-enhanced magnetic resonance imaging reflects co-activation of β-catenin and hepatocyte nuclear factor 4α in hepatocellular carcinoma. | 2018 Feb |
4 |
| 8 |
25668519 | Hepatocellular Carcinoma with β-Catenin Mutation: Imaging and Pathologic Characteristics. | 2015 Jun |
1 |
| 9 |
22911100 | Beta-catenin-activated hepatocellular adenoma showing hyperintensity on hepatobiliary-phase gadoxetic-enhanced magnetic resonance imaging and overexpression of OATP8. | 2012 Nov |
1 |